NCT00387400 2023-08-04
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Canadian Cancer Trials Group
Phase 1 Completed
Canadian Cancer Trials Group
City of Hope Medical Center
City of Hope Medical Center
European Organisation for Research and Treatment of Cancer - EORTC